Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Standard-of-Care Medication Withdrawal in Patients With Obstructive Hypertrophic Cardiomyopathy Receiving Aficamten in FOREST-HCM.
Masri A, Choudhury L, Barriales-Villa R, Elliott P, Maron MS, Nassif ME, Oreziak A, Owens AT, Saberi S, Tower-Rader A, Rader F, Garcia-Pavia P, Olivotto I, Nagueh SF, Wang A, Heitner SB, Jacoby DL, Kupfer S, Malik FI, Melloni C, Meng L, Wei J, Sherrid MV, Abraham TP; FOREST-HCM Investigators. Masri A, et al. Among authors: garcia pavia p. J Am Coll Cardiol. 2024 Nov 5;84(19):1839-1849. doi: 10.1016/j.jacc.2024.09.002. J Am Coll Cardiol. 2024. PMID: 39477631
Incidence and predictors of sudden death in patients with cardiac amyloidosis.
de Frutos F, Saturi G, Gonzalez-Lopez E, Sguazzotti M, Dominguez F, Ponziani A, Cabrera-Romero E, Caponetti AG, Lozano S, Massa P, Peiro-Aventin B, Accietto A, Mora-Ayestarán N, Giovannetti A, Castro-Urda V, Gagliardi C, Cobo-Marcos M, Rios-Tamayo R, Biagini E, Gomez-Bueno M, Galiè N, Segovia-Cubero J, Longhi S, Garcia-Pavia P. de Frutos F, et al. Among authors: garcia pavia p. Amyloid. 2024 Oct 24:1-5. doi: 10.1080/13506129.2024.2414295. Online ahead of print. Amyloid. 2024. PMID: 39449197
Genetic Landscape of Patients With Dilated Cardiomyopathy and a Systemic Immune-Mediated Disease.
Stroeks SLVM, Henkens MTHM, Dominguez F, Merlo M, Hellebrekers DMEI, Gonzalez-Lopez E, Dal Ferro M, Ochoa JP, Venturelli F, Claes GRF, Venner MFGHM, Krapels IPC, Vanhoutte EK, van Paassen P, van den Wijngaard A, Sikking MA, van Leeuwen R, Abdul Hamid M, Li X, Brunner HG, Sinagra G, Garcia-Pavia P, Heymans SRB, Verdonschot JAJ. Stroeks SLVM, et al. Among authors: garcia pavia p. JACC Heart Fail. 2024 Oct 5:S2213-1779(24)00617-6. doi: 10.1016/j.jchf.2024.08.011. Online ahead of print. JACC Heart Fail. 2024. PMID: 39425739 Free article.
Prevalence of cardiac amyloidosis among elderly patients with recent-onset atrial fibrillation. The PREVAL-ATTR study.
Remior-Pérez P, Gómez-Molina M, García-Rodríguez D, Gallego-Delgado M, Mohamed-Salem L, de Haro-Del Moral J, Hernández-Terciado F, de Castro D, Eiros-Bachiller R, Dominguez F, Gonzalez-Lopez E, Villacorta E, Pascual-Figal DA, Garcia-Pavia P. Remior-Pérez P, et al. Among authors: garcia pavia p. Can J Cardiol. 2024 Oct 16:S0828-282X(24)01028-6. doi: 10.1016/j.cjca.2024.10.010. Online ahead of print. Can J Cardiol. 2024. PMID: 39424187 Free article.
Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Maron MS, Masri A, Nassif ME, Barriales-Villa R, Abraham TP, Arad M, Cardim N, Choudhury L, Claggett B, Coats CJ, Düngen HD, Garcia-Pavia P, Hagège AA, Januzzi JL, Kulac I, Lee MMY, Lewis GD, Ma CS, Michels M, Oreziak A, Owens AT, Spertus JA, Solomon SD, Tfelt-Hansen J, van Sinttruije M, Veselka J, Watkins HC, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Olivotto I; SEQUOIA-HCM Investigators. Maron MS, et al. Among authors: garcia pavia p. J Am Coll Cardiol. 2024 Nov 5;84(19):1821-1831. doi: 10.1016/j.jacc.2024.09.003. Epub 2024 Sep 30. J Am Coll Cardiol. 2024. PMID: 39352339 Free article. Clinical Trial.
Aficamten and Cardiopulmonary Exercise Test Performance: A Substudy of the SEQUOIA-HCM Randomized Clinical Trial.
Lee MMY, Masri A, Nassif ME, Barriales-Villa R, Abraham TP, Claggett BL, Coats CJ, Gimeno JR, Kulac IJ, Landsteiner I, Ma C, Maron MS, Olivotto I, Owens AT, Solomon SD, Veselka J, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Lewis GD; SEQUOIA-HCM Investigators. Lee MMY, et al. JAMA Cardiol. 2024 Sep 4:e242781. doi: 10.1001/jamacardio.2024.2781. Online ahead of print. JAMA Cardiol. 2024. PMID: 39230885 Free PMC article.
Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.
Sherrod CF 4th, Saberi S, Nassif ME, Claggett BL, Coats CJ, Garcia-Pavia P, Januzzi JL, Lewis GD, Ma C, Maron MS, Miao ZM, Olivotto I, Veselka J, Butzner M, Jacoby DL, Heitner SB, Kupfer S, Malik FI, Meng L, Wohltman A, Spertus JA. Sherrod CF 4th, et al. Among authors: garcia pavia p. J Am Coll Cardiol. 2024 Nov 5;84(19):1773-1785. doi: 10.1016/j.jacc.2024.08.014. Epub 2024 Sep 1. J Am Coll Cardiol. 2024. PMID: 39217569 Free article. Clinical Trial.
306 results